These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 18194504)

  • 1. Rapid protection of the gastroduodenal mucosa against aspirin-induced damage by rabeprazole.
    Irani S; Krevsky B; Desipio J; Kim-Jaffe J; Maqbool S; Fisher RS
    Aliment Pharmacol Ther; 2008 Mar; 27(6):498-503. PubMed ID: 18194504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Helicobacter pylori eradication on anti-thrombotic dose aspirin-induced gastroduodenal mucosal injury.
    Giral A; Ozdogan O; Celikel CA; Tozun N; Ulusoy NB; Kalayci C
    J Gastroenterol Hepatol; 2004 Jul; 19(7):773-7. PubMed ID: 15209624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between low-dose aspirin-induced gastric mucosal injury and intragastric pH in healthy volunteers.
    Nishino M; Sugimoto M; Kodaira C; Yamade M; Shirai N; Ikuma M; Tanaka T; Sugimura H; Hishida A; Furuta T
    Dig Dis Sci; 2010 Jun; 55(6):1627-36. PubMed ID: 19672708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of rabeprazole alone or in combination with H2 receptor blocker on intragastric pH: a pilot study.
    Törüner M; Bektaş M; Cetinkaya H; Soykan I; Ozden A
    Turk J Gastroenterol; 2004 Dec; 15(4):225-8. PubMed ID: 16249975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
    Goldstein JL; Huang B; Amer F; Christopoulos NG
    Clin Ther; 2004 Oct; 26(10):1637-43. PubMed ID: 15598480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Esophageal mucosal injury with low-dose aspirin and its prevention by rabeprazole.
    Sugimoto M; Nishino M; Kodaira C; Yamade M; Ikuma M; Tanaka T; Sugimura H; Hishida A; Furuta T
    J Clin Pharmacol; 2010 Mar; 50(3):320-30. PubMed ID: 19940233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ability of rabeprazole to prevent gastric mucosal damage from clopidogrel and low doses of aspirin depends on CYP2C19 genotype.
    Uotani T; Sugimoto M; Nishino M; Kodaira C; Yamade M; Sahara S; Yamada T; Osawa S; Sugimoto K; Tanaka T; Umemura K; Watanabe H; Miyajima H; Furuta T
    Clin Gastroenterol Hepatol; 2012 Aug; 10(8):879-885.e2. PubMed ID: 22542748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ranitidine protects against gastroduodenal mucosal damage associated with chronic aspirin therapy.
    Berkowitz JM; Rogenes PR; Sharp JT; Warner CW
    Arch Intern Med; 1987 Dec; 147(12):2137-9. PubMed ID: 3689065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs.
    Pilotto A; Franceschi M; Leandro G; Paris F; Cascavilla L; Longo MG; Niro V; Andriulli A; Scarcelli C; Di Mario F
    Aliment Pharmacol Ther; 2004 Nov; 20(10):1091-7. PubMed ID: 15569111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study of intragastric acidity during post-breakfast and pre-dinner administration of low-dose proton pump inhibitors: a randomized three-way crossover study.
    Miki M; Adachi K; Azumi T; Koshino K; Furuta K; Kinoshita Y
    Aliment Pharmacol Ther; 2006 Nov; 24(10):1445-51. PubMed ID: 17032285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of low-dose rabeprazole and omeprazole on gastric acidity: results of a double blind, randomized, placebo-controlled, three-way crossover study in healthy subjects.
    Bruley des Varannes S; Gharib H; Bicheler V; Bost R; Bonaz B; Stanescu L; Delchier JC; Bonnot-Marlier S
    Aliment Pharmacol Ther; 2004 Oct; 20(8):899-907. PubMed ID: 15479362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, placebo-controlled study of the effects of naproxen, aspirin, celecoxib or clopidogrel on gastroduodenal mucosal healing.
    Dikman A; Sanyal S; VON Althann C; Whitson M; Desai J; Bodian C; Brooks A; Bamji N; Cohen L; Miller K; Aisenberg J
    Aliment Pharmacol Ther; 2009 Apr; 29(7):781-91. PubMed ID: 19183162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of esomeprazole and rabeprazole on intragastric pH in healthy Chinese: an open, randomized crossover trial.
    Li ZS; Zhan XB; Xu GM; Cheng NN; Liao Z
    J Gastroenterol Hepatol; 2007 Jun; 22(6):815-20. PubMed ID: 17565634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immediate acid-suppressing effects of ranitidine hydrochloride and rabeprazole sodium following initial administration and reintroduction: A randomized, cross-over study using wireless pH monitoring capsules.
    Ono S; Kato M; Ono Y; Imai A; Yoshida T; Shimizu Y; Asaka M
    J Gastroenterol Hepatol; 2009 Apr; 24(4):639-45. PubMed ID: 19032447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does concomitant use of paracetamol potentiate the gastroduodenal mucosal injury associated with aspirin? A prospective, randomised, pilot study.
    Boike JR; Kao R; Meyer D; Markle B; Rosenberg J; Niebruegge J; Stein AC; Berkes J; Goldstein JL
    Aliment Pharmacol Ther; 2012 Aug; 36(4):391-7. PubMed ID: 22742578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of alendronate on gastric and duodenal mucosa.
    Lanza F; Rack MF; Simon TJ; Lombardi A; Reyes R; Suryawanshi S
    Am J Gastroenterol; 1998 May; 93(5):753-7. PubMed ID: 9625122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prophylactic effect of Misoprostol on gastric lesions induced by aspirin (ASA) in healthy subjects].
    Naves J; Santoyo R; Morales I
    Rev Gastroenterol Mex; 1989; 54(4):203-6. PubMed ID: 2515571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind, placebo-controlled, 6-day evaluation of two doses of misoprostol in gastroduodenal mucosal protection against damage from aspirin and effect on bowel habits.
    Lanza FL; Kochman RL; Geis GS; Rack EM; Deysach LG
    Am J Gastroenterol; 1991 Dec; 86(12):1743-8. PubMed ID: 1962619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prospective comparative study on protective effect of the proton pump inhibitor and the prostaglandin analog on H. pylori-negative gastric mucosa of healthy subjects against low-dose aspirin].
    Kotaira J
    Hokkaido Igaku Zasshi; 2004 Jul; 79(4):347-51. PubMed ID: 15373207
    [No Abstract]   [Full Text] [Related]  

  • 20. A multicenter, randomized, double-blind, active-comparator, placebo-controlled, parallel-group comparison of the incidence of endoscopic gastric and duodenal ulcer rates with valdecoxib or naproxen in healthy subjects aged 65 to 75 years.
    Goldstein JL; Aisenberg J; Lanza F; Schwartz H; Sands GH; Berger MF; Pan S
    Clin Ther; 2006 Mar; 28(3):340-51. PubMed ID: 16750449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.